We have observed
11 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 26, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
BIOMARKERS FOR ACUTE KIDNEY INJURY
METHODS AND SYSTEMS FOR COLLIMATING
Molecular gradient coil for hybrid SPECT-MRI imaging system
A LACTONASE DERIVED FROM CANDIDA BOMBICOLA AND USES THEREOF
HIGH PERFORMANCE BIODEPOSITION FOR STRENGTHENING OF MATERIALS
Quantification of glucocorticoids in fish scales as biomarkers for chronic stress
TREATMENT OF CLAY OR DREDGED SEDIMENT WITH POLYMER INCREASES ADSORPTION CHARACTERISTICS
USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS
METHODS TO PRODUCE BOLAAMPHIPHILIC GLYCOLIPIDS
DETECTION OF PULMONARY VEIN ISOLATION